GI
OPNT

GAMCO Investors’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

GAMCO Investors’s Portfolio OPNT Stock Details OPNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,000
Closed -$203K – 911
2022
Q4 		$203K Buy
+10,000
New +$153K ﹤0.01% 829

GAMCO Investors's OPNT Position: Q1 2023 in Review

GAMCO Investors sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q1 2023, closing a stake of 10,000 shares — an estimated $203K sold.

GAMCO Investors first reported a position in OPNT in Q4 2022 and held it in 1 quarter. The position peaked at $203K in Q4 2022. 0 funds tracked by Wall St. Rank hold OPNT as of Q1 2023.

  • GAMCO Investors reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • GAMCO Investors sold 10,000 Opiant Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $203K.
  • GAMCO Investors first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • GAMCO Investors's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $203K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on GAMCO Investors's 13F filing for Q1 2023, filed 12 May 2023.